β-blockade in noncardiac surgery: Outcome at all levels of cardiac risk

Archives of Surgery

Volumn 143, Issue 10, 2008, Pages 940-944

  Kaafarani, Haytham M A ^a,b,c   Atluri, Prasad V ^d   Thornby, John ^e   Itani, Kamal M F ^b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; PROPRANOLOL;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART ARREST; HEART INFARCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STROKE; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 54349100976     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.10.940     Document Type: Article

References (14)

1. Landesberg G, Mosseri M, Zahger D, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol. 2001;37(7):1839-1845.
2. Parker SD, Breslow MJ, Frank SM, et al; Perioperative Ischemia Randomized Anesthesia Trial Study Group. Catecholamine and cortisol responses to lower extremity revascularization: correlation with outcome variables. Crit Care Med. 1995;23(12):1954-1961.
3. London MJ. Multilead precordial ST-segment monitoring: "the next generation?" Anesthesiology. 2002;96(2):259-261.
4. Stone JG, Foëx P, Sear JW, et al. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a β-adrenergic blocking agent. Anesthesiology. 1988;68(4):495-500.
5. Pasternack PF, Imparato AM, Baumann FG, et al. The hemodynamics of β-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation. 1987;76(3, pt 2):III1-III7.
6. Mangano DT, Layug EL, Wallace A, et al; Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335(23):1713-1720.
7. Poldermans D, Boersma E, Bax JJ, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341(24):1789- 1794.
8. Yang H, Raymer K, Butler R, et al. The effects of perioperative β-blockade: results of the Metoprolol After Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152(5):983-990.
9. Feringa HH, Bax JJ, Boersma E, et al. High-dose β-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation. 2006;114(1)(suppl):I344-I349.
10. Fleisher LA, Beckman JA, Brown KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative β-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation. 2006;113(22):2662-2674.
11. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839-1847.
12. Eagle KA, Brundage BH, Chaitman BR, et al; Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation. 1996;93(6):1278-1317.
13. Lindenauer PK, Pekow P, Wang K, et al. Perioperative β-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361.
14. Leosco D, Rengo G, Iaccarino G, et al. Exercise training and β-blocker treatment ameliorate age-dependent impairment of β-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation. Am J Physiol Heart Circ Physiol. 2007;293(3):H1596-H1603.